SCISPARC LTD (SPRC) Stock Price & Overview

NASDAQ:SPRC • IL0010951403

Current stock price

4.63 USD
-0.03 (-0.64%)
Last:

The current stock price of SPRC is 4.63 USD. Today SPRC is down by -0.64%. In the past month the price decreased by -1.65%. In the past year, price decreased by -92.49%.

SPRC Key Statistics

52-Week Range3.6001 - 94.5
Current SPRC stock price positioned within its 52-week range.
1-Month Range3.6001 - 6.2432
Current SPRC stock price positioned within its 1-month range.
Market Cap
2.639M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-203.76
Dividend Yield
N/A

SPRC Stock Performance

Today
-0.64%
1 Week
+6.19%
1 Month
-1.65%
3 Months
-64.76%
Longer-term
6 Months -89.22%
1 Year -92.49%
2 Years -98.62%
3 Years -99.79%
5 Years N/A
10 Years N/A

SPRC Stock Chart

SCISPARC LTD / SPRC Daily stock chart

SPRC Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to SPRC. When comparing the yearly performance of all stocks, SPRC is a bad performer in the overall market: 98.72% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SPRC Earnings

Next Earnings DateN/A
Last Earnings DateApr 24, 2025
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

SPRC Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

SPRC Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

SPRC Financial Highlights

Over the last trailing twelve months SPRC reported a non-GAAP Earnings per Share(EPS) of -203.76. The EPS increased by 91.4% compared to the year before.


Income Statements
Revenue(TTM)1.31M
Net Income(TTM)-6.28M
Industry RankSector Rank
PM (TTM) N/A
ROA -122.18%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)91.4%
Revenue 1Y (TTM)-54.64%

SPRC Ownership

Ownership
Inst Owners1.32%
Shares570.00K
Float450.00K
Ins Owners19.81%
Short Float %N/A
Short Ratio0.13

About SPRC

Company Profile

SPRC logo image SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Company Info

IPO: 2021-12-22

SCISPARC LTD

20 Raul Wallenberg Street, Tower A

TEL AVIV-YAFO IL

Employees: 2

SPRC Company Website

SPRC Investor Relations

Phone: 97236103100

SCISPARC LTD / SPRC FAQ

Can you describe the business of SCISPARC LTD?

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.


What is the stock price of SCISPARC LTD today?

The current stock price of SPRC is 4.63 USD. The price decreased by -0.64% in the last trading session.


Does SCISPARC LTD pay dividends?

SPRC does not pay a dividend.


What is the ChartMill rating of SCISPARC LTD stock?

SPRC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Which stock exchange lists SPRC stock?

SPRC stock is listed on the Nasdaq exchange.


What is the Price/Earnings (PE) ratio of SCISPARC LTD (SPRC)?

SCISPARC LTD (SPRC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-203.76).